Carl Zeiss Meditec AG
CZMWY | OTC
$40.23
+$0.02 (+0.05%)
At close: Nov 5, 2026, 3:25 PM ET
$40.40
+$0.17 (+0.42%)
Pre-market:
Nov 5, 2026, 11:29 AM ET
Fiscal Year Period Ending | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.23B | 2.07B | 2.09B | 1.9B | 1.65B | 1.34B |
Cost of Revenue | 1.05B | 977.5M | 883.54M | 775.24M | 679.57M | 589.94M |
Gross Profit | 1.18B | 1.09B | 1.21B | 1.13B | 967.21M | 745.52M |
Operating Income | 223.32M | 194.45M | 348.12M | 396.88M | 373.61M | n/a |
Interest Income | 6.57M | 23.27M | 28.11M | 13.25M | 1.56M | 1.46M |
Pretax Income | 193.89M | 240.87M | 412.56M | 403.49M | 339.05M | 178.72M |
Net Income | 141.21M | 178.73M | 290.4M | 293.91M | 236.28M | 122.39M |
Selling & General & Admin | 626.52M | 569.21M | 504.06M | 438.06M | 363.98M | 349.16M |
Research & Development | 326.28M | 343.09M | 349.28M | 291.37M | 232.07M | 218.8M |
Other Expenses | -917K | -18.12M | 4.31M | 1.29M | -2.45M | 177.55M |
Operating Expenses | 951.88M | 894.18M | 857.64M | 730.72M | 593.6M | 745.52M |
Interest Expense | 26.62M | -14.58M | 15.25M | 9.1M | 8.58M | 27.27M |
Selling & Marketing Expenses | 495.1M | 458.2M | 420.28M | 360.18M | 303.23M | 292.84M |
Cost & Expenses | 2B | 1.87B | 1.74B | 1.51B | 1.27B | 1.34B |
Income Tax Expense | 51.55M | 60.71M | 120.56M | 107.58M | 101.53M | 55.3M |
Shares Outstanding (Basic) | 87.54M | 88.85M | 89.44M | 89.44M | 89.44M | 89.44M |
Shares Outstanding (Diluted) | 87.54M | 88.85M | 89.44M | 89.44M | 89.44M | 89.44M |
EPS (Basic) | 1.61 | 2.01 | 3.25 | 3.29 | 2.64 | 1.37 |
EPS (Diluted) | 1.61 | 2.01 | 3.25 | 3.29 | 2.64 | 1.37 |
EBITDA | 346.89M | 403.06M | 501.88M | 482.85M | 410M | 267.03M |
EBIT | 220.52M | 270.29M | 427.81M | 413.08M | 348.42M | 206.61M |
Depreciation & Amortization | 126.38M | 132.77M | 74.06M | 69.77M | 61.58M | 60.43M |
Add to Watchlist
Select watchlists to add or remove CZMWY